Long-term follow up of the combination of ofatumumab, high-dose methylprednisolone, and lenalidomide for untreated chronic lymphocytic leukemia with biomarker analysis.

Julio C ChavezAriel GrajalesJose Sandoval-SusElyce TurbaLisa NodzonAngimar Uriepero-PalmaMohammad Ammad-Ud-DinEva SahakianRami KomrokjiLubomir SokolFrederick L LockeBijal ShahJeffrey LancetEduardo M SotomayorMohamed A Kharfan-DabajaCeleste BelloJavier Pinilla-Ibarz

Published in: Clinical lymphoma, myeloma & leukemia (2024)

The funders had no role in the study.

Keyphrases

chronic lymphocytic leukemia
high dose
stem cell transplantation
low dose
multiple myeloma